Q413299: Difference between revisions

@@ label / zh-hans / label / zh-hans @@
-安维汀
+贝伐珠单抗
@@ label / zh-hant / label / zh-hant @@
-安維汀
+貝伐珠單抗
@@ label / zh-hk / label / zh-hk @@
-安維汀
@@ label / zh-cn / label / zh-cn @@
-安维汀
+贝伐珠单抗
@@ label / zh-sg / label / zh-sg @@
-安维汀
@@ label / zh-tw / label / zh-tw @@
-安維汀
@@ label / ru / label / ru @@
-Бевацизумаб
+бевацизумаб
@@ label / tr / label / tr @@
-Bevacizumab
+Bevasizumab
@@ label / sl / label / sl @@
-Bevacizumab
+bevacizumab
@@ label / hr / label / hr @@
-Bevacizumab
+bevacizumab
@@ label / nb / label / nb @@
+bevacizumab
@@ aliases / zh / 0 / aliases / zh / 0 @@
+安维汀®
@@ aliases / zh / 1 / aliases / zh / 1 @@
+癌思停®
@@ aliases / zh / 2 / aliases / zh / 2 @@
+达攸同®
@@ aliases / zh / 3 / aliases / zh / 3 @@
-癌思停
@@ aliases / zh / 4 / aliases / zh / 4 @@
-安维汀
@@ aliases / zh / 5 / aliases / zh / 5 @@
-达攸同
@@ aliases / ja / 0 / aliases / ja / 0 @@
+ベヴァシズマブ
@@ aliases / hr / 0 / aliases / hr / 0 @@
+avastin
@@ aliases / hr / 1 / aliases / hr / 1 @@
-Avastin
@@ description / tr / description / tr @@
+farmasötik ilaç
@@ description / ko / description / ko @@
+수많은 유형의 암과 특정 눈병을 치료하기 위해 사용되는 약물
@@ description / zh / description / zh @@
+药物
@@ Property / instance of @@
-medication
@@ Property / instance of: medication / rank @@
-Normal rank
@@ Property / instance of: medication / reference @@
-stated in: DrugBank
DrugBank ID: 00112
language of work or name: English
title: Bevacizumab (English)
publication date: 17 November 2015Timestamp +2015-11-17T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2015-11-17T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / instance of @@
-chemical compound
@@ Property / instance of: chemical compound / rank @@
-Normal rank
@@ Property / instance of: chemical compound / reference @@
-stated in: DrugBank
DrugBank ID: 00112
language of work or name: English
title: Bevacizumab (English)
publication date: 17 November 2015Timestamp +2015-11-17T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2015-11-17T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / instance of @@
-biopharmaceutical
@@ Property / instance of: biopharmaceutical / rank @@
-Normal rank
@@ Property / instance of: biopharmaceutical / reference @@
-stated in: DrugBank
DrugBank ID: 00112
language of work or name: English
title: Bevacizumab (English)
publication date: 17 November 2015Timestamp +2015-11-17T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2015-11-17T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / instance of @@
-monoclonal antibody
@@ Property / instance of: monoclonal antibody / rank @@
-Normal rank
@@ Property / instance of: monoclonal antibody / reference @@
-stated in: DrugBank
DrugBank ID: 00112
language of work or name: English
title: Bevacizumab (English)
publication date: 17 November 2015Timestamp +2015-11-17T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2015-11-17T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / instance of @@
-essential medicine
@@ Property / instance of: essential medicine / rank @@
-Normal rank
@@ Property / instance of @@
-female reproductive toxicant
@@ Property / instance of: female reproductive toxicant / rank @@
-Normal rank
@@ Property / instance of: female reproductive toxicant / reference @@
-stated in: California Proposition 65 list of chemicals
retrieved: 19 February 2020Timestamp +2020-02-19T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
reference URL: https://oehha.ca.gov/chemicals/bevacizumab
-Timestamp
++2020-02-19T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / instance of @@
-developmental toxicant
@@ Property / instance of: developmental toxicant / rank @@
-Deprecated rank
@@ Property / instance of: developmental toxicant / qualifier @@
-reason for deprecated rank: rectification
@@ Property / instance of: developmental toxicant / reference @@
-stated in: California Proposition 65 list of chemicals
retrieved: 25 February 2020Timestamp +2020-02-25T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
reference URL: https://oehha.ca.gov/chemicals/bevacizumab
-Timestamp
++2020-02-25T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / DrugBank ID @@
@@ Property / DrugBank ID: 00112 / rank @@
-Normal rank
@@ Property / DrugBank ID: 00112 / reference @@
-stated in: DrugBank
DrugBank ID: 00112
language of work or name: English
title: Bevacizumab (English)
publication date: 17 November 2015Timestamp +2015-11-17T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2015-11-17T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / DrugBank ID: 00112 / reference @@
-reference URL: https://www.drugbank.ca/releases/latest#open-data
retrieved: April 2018Timestamp +2018-04-24T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 month
Before 0
After 0
-Timestamp
++2018-04-24T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+month
 Before
 After
@@ Property / Encyclopædia Britannica Online ID: topic/bevacizumab / qualifier @@
+subject named as: bevacizumab
@@ Property / instance of @@
+type of chemical entity
@@ Property / instance of: type of chemical entity / rank @@
+Normal rank
@@ Property / DrugBank ID @@
+DB00112
@@ Property / DrugBank ID: DB00112 / rank @@
+Normal rank
@@ Property / subject has role @@
+monoclonal antibody
@@ Property / subject has role: monoclonal antibody / rank @@
+Normal rank
@@ Property / subject has role: monoclonal antibody / reference @@
+stated in: DrugBank
DrugBank ID: 00112
language of work or name: English
title: Bevacizumab (English)
publication date: 17 November 2015Timestamp +2015-11-17T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2015-11-17T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / subject has role @@
+female reproductive toxicant
@@ Property / subject has role: female reproductive toxicant / rank @@
+Normal rank
@@ Property / subject has role: female reproductive toxicant / reference @@
+stated in: California Proposition 65 list of chemicals
retrieved: 19 February 2020Timestamp +2020-02-19T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
reference URL: https://oehha.ca.gov/chemicals/bevacizumab
-Timestamp
++2020-02-19T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / subject has role @@
+developmental toxicant
@@ Property / subject has role: developmental toxicant / rank @@
+Deprecated rank
@@ Property / subject has role: developmental toxicant / qualifier @@
+reason for deprecated rank: rectification
@@ Property / subject has role: developmental toxicant / reference @@
+stated in: California Proposition 65 list of chemicals
retrieved: 25 February 2020Timestamp +2020-02-25T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
reference URL: https://oehha.ca.gov/chemicals/bevacizumab
-Timestamp
++2020-02-25T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / subject has role @@
+essential medicine
@@ Property / subject has role: essential medicine / rank @@
+Normal rank
@@ Property / medical condition treated @@
+low-grade serous carcinoma
@@ Property / medical condition treated: low-grade serous carcinoma / rank @@
+Normal rank
@@ Property / medical condition treated: low-grade serous carcinoma / reference @@
+reference URL: https://cureourovariancancer.org/wp-content/uploads/2019/08/NCCN-ovarian.pdf
@@ Property / WikiProjectMed ID @@
+Bevacizumab
@@ Property / WikiProjectMed ID: Bevacizumab / rank @@
+Normal rank
@@ Property / has use @@
+medication
@@ Property / has use: medication / rank @@
+Normal rank
@@ Property / has use: medication / reference @@
+stated in: DrugBank
DrugBank ID: 00112
language of work or name: English
title: Bevacizumab (English)
publication date: 17 November 2015Timestamp +2015-11-17T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2015-11-17T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / has use @@
+biopharmaceutical
@@ Property / has use: biopharmaceutical / rank @@
+Normal rank
@@ Property / has use: biopharmaceutical / reference @@
+stated in: DrugBank
DrugBank ID: 00112
language of work or name: English
title: Bevacizumab (English)
publication date: 17 November 2015Timestamp +2015-11-17T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2015-11-17T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / UMLS CUI @@
+C0796392
@@ Property / UMLS CUI: C0796392 / rank @@
+Normal rank
@@ Property / UMLS CUI: C0796392 / reference @@
+stated in: WikiUMLS: Aligning UMLS to Wikipedia via Cross-lingual Neural Ranking
@@ Property / subclass of @@
+chemical compound
@@ Property / subclass of: chemical compound / rank @@
+Normal rank
@@ links / trwiki / name / links / trwiki / name @@
-Bevacizumab
+Bevasizumab